These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20677340)

  • 1. ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS.
    Jee SR; Morales W; Low K; Chang C; Zhu A; Pokkunuri V; Chatterjee S; Soffer E; Conklin JL; Pimentel M
    World J Gastroenterol; 2010 Aug; 16(29):3680-6. PubMed ID: 20677340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.
    Pimentel M; Morales W; Pokkunuri V; Brikos C; Kim SM; Kim SE; Triantafyllou K; Weitsman S; Marsh Z; Marsh E; Chua KS; Srinivasan S; Barlow GM; Chang C
    Dig Dis Sci; 2015 May; 60(5):1195-205. PubMed ID: 25424202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model.
    Chen B; Zhu S; Du L; He H; Kim JJ; Dai N
    Scand J Gastroenterol; 2017 Oct; 52(10):1065-1071. PubMed ID: 28679338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new rat model links two contemporary theories in irritable bowel syndrome.
    Pimentel M; Chatterjee S; Chang C; Low K; Song Y; Liu C; Morales W; Ali L; Lezcano S; Conklin J; Finegold S
    Dig Dis Sci; 2008 Apr; 53(4):982-9. PubMed ID: 17934822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial bowel changes.
    Sung J; Morales W; Kim G; Pokkunuri V; Weitsman S; Rooks E; Marsh Z; Barlow GM; Chang C; Pimentel M
    Neurogastroenterol Motil; 2013 Jun; 25(6):529-37. PubMed ID: 23521493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic histological changes of the small bowel secondary to C. jejuni infection in a rat model for post-infectious IBS.
    Morales W; Pimentel M; Hwang L; Kunkel D; Pokkunuri V; Basseri B; Low K; Wang H; Conklin JL; Chang C
    Dig Dis Sci; 2011 Sep; 56(9):2575-84. PubMed ID: 21409374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome.
    Pokkunuri V; Pimentel M; Morales W; Jee SR; Alpern J; Weitsman S; Marsh Z; Low K; Hwang L; Khoshini R; Barlow GM; Wang H; Chang C
    J Neurogastroenterol Motil; 2012 Oct; 18(4):434-42. PubMed ID: 23106005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBS.
    Pimentel M; Morales W; Jee SR; Low K; Hwang L; Pokkunuri V; Mirocha J; Conklin J; Chang C
    Dig Dis Sci; 2011 Jul; 56(7):1962-6. PubMed ID: 21222158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome.
    Morales W; Triantafyllou K; Parodi G; Weitsman S; Park SC; Rezaie A; Pichetshote N; Lin E; Pimentel M
    Neurogastroenterol Motil; 2020 Oct; 32(10):e13875. PubMed ID: 32436301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
    Posserud I; Stotzer PO; Björnsson ES; Abrahamsson H; Simrén M
    Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly
    Wu KQ; Sun WJ; Li N; Chen YQ; Wei YL; Chen DF
    Scand J Gastroenterol; 2019 Dec; 54(12):1419-1425. PubMed ID: 31765575
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.
    Spiegel BM
    Clin Gastroenterol Hepatol; 2011 Jun; 9(6):461-9; quiz e59. PubMed ID: 21397724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress.
    Grover M; Kanazawa M; Palsson OS; Chitkara DK; Gangarosa LM; Drossman DA; Whitehead WE
    Neurogastroenterol Motil; 2008 Sep; 20(9):998-1008. PubMed ID: 18482250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
    Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X
    Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis.
    Chen B; Kim JJ; Zhang Y; Du L; Dai N
    J Gastroenterol; 2018 Jul; 53(7):807-818. PubMed ID: 29761234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Barrier in Post-
    Omarova S; Awad K; Moos V; Püning C; Gölz G; Schulzke JD; Bücker R
    Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
    Leventogiannis K; Gkolfakis P; Spithakis G; Tsatali A; Pistiki A; Sioulas A; Giamarellos-Bourboulis EJ; Triantafyllou K
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):627-634. PubMed ID: 29508268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].
    Łokieć K; Klupińska G; Walecka-Kapica E; Błońska A
    Pol Merkur Lekarski; 2014 May; 36(215):307-10. PubMed ID: 24964506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.